Return to search

BlueMountain beefs up team with two new hires

BlueMountain Capital Management has hired Ameya Agge and Matt Jameson as senior investing professionals. In these newly created roles, both Agge and Jameson will source, evaluate, and execute healthcare-related private investments. Previously, Agge worked at Apax Partners while Jameson was at Highland Capital Management.


NEW YORK, JULY 23, 2018 – BlueMountain Capital Management, LLC (“BlueMountain”), a private diversified alternative asset management firm, today announced that Ameya Agge and Matt Jameson have joined as senior investing professionals to source, evaluate, and execute healthcare-related private investments. Both are newly-created positions reporting to Jim Pieri, Head of Private Healthcare.

“Just as the financial services industry went through a major transition in recent years, many healthcare sectors are beginning to go through substantial transformation that will dynamically evolve over the next decade, thus increasing the need for nontraditional capital providers,” said Andrew Feldstein, Co-Founder and Chief Investment Officer of BlueMountain. “Private investments in healthcare continue to complement our private investment strategies in specialty finance and various special situations.”

“End market demand for healthcare services continues to exhibit predictably strong growth rates. However, a combination of rising costs, ineffective delivery and misaligned incentives are accelerating necessary market structure reform and business model change,” said Mr. Pieri. “These factors impact market participants unequally and create attractive investment opportunities,” he explained. “As a result, the need for flexible capital solutions has increased substantially, creating a unique, persistent and high barrier-to-access opportunity for our investors.”

Mr. Pieri’s team has made more than $500 million in privately negotiated and structured investments across the capital structure in healthcare in recent years, including investments in post acute & long-term care, behavioral health, acute care and physician practice management companies, complementing BlueMountain’s expansive presence in more liquid debt and equity markets.

Mr. Agge joins from Apax Partners, where he specialized in private healthcare investments in the U.S. and Europe. Over the last five years at Apax, Mr. Agge deployed over $1.5 billion in a range of healthcare investments. In addition, he served on the boards of several healthcare platform companies. Prior to joining Apax, Mr. Agge worked for Dr. Reddy’s Laboratories and with McKinsey & Company. He received an M.B.A. with Honors from the Wharton School at the University of Pennsylvania. Mr. Agge also received Master’s and Bachelor’s degrees in Chemical Engineering from the Massachusetts Institute of Technology and the Indian Institute of Technology, Mumbai, respectively.

Mr. Jameson joins from Highland Capital Management, where he was a Managing Director and Co-Head of Private Equity. He also served on the investment committee of the healthcare-focused Stonebridge-Highland Private Equity Fund. While at Highland, Mr. Jameson originated and/or managed over $600 million of healthcare related investments. Mr. Jameson has served on the boards of Cornerstone Healthcare Group, Tandem Hospital Partners and American HomePatient, where he was the Chairman. Prior to joining Highland, Mr. Jameson spent more than a decade working in the private equity and strategy consulting industries in North America, Europe and Africa. He received a B.S. in Accounting from Case Western Reserve University and has earned the CFA designation.

The hiring of Messrs. Agge and Jameson come as BlueMountain has built out its Portfolio Company Management team, which supports the firm’s investments in healthcare, specialty finance and special situations. New additions earlier this year to that team, led by Jon Weber, include Murtaza Ali, Jigar Shah, and Suraj Ramdas.

About BlueMountain Capital Management, LLC
BlueMountain Capital Management, LLC (“BlueMountain”) is a leading diversified alternative asset management firm managing over $21 billion of assets. BlueMountain’s diverse team of professionals in New York and London is supported by the firm’s institutionalized and proprietary infrastructure, including specialized operations and risk management technology.